DAIZIX

This brand name is authorized in Nigeria.

Active ingredients

The drug DAIZIX contains one active pharmaceutical ingredient (API):

1	Azithromycin UNII JTE4MNN1MD - AZITHROMYCIN MONOHYDRATE
	Azithromycin is a macrolide antibiotic belonging to the azalide group. The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The mechanism of action of azithromycin is based upon the suppression of bacterial protein synthesis by means of binding to the ribosomal 50S sub-unit and inhibition of peptide translocation.
	Read more about Azithromycin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-6519	Tablet	Daizix Tablets TAB 250 mg 1 x 6's	Tablet 86 RNW-PP-225274 DAIZIX TABLETS AZITHROMYCIN 250MG AZITHROMYCIN 250MG, CROSCARMELLOSE SODIUM 58MG, MICROCRYSTALLINE CELLULOSE 192MG, PVK 30 208MG, MAGNESIUM STEARATE 20MG, ALCOHOL 150MG, PURIFIED WATER 87.2MG B4-6519 Drugs Imported Products 16 Prescription Only Medicine (POM) 8/11/2021 DAITECH PHARMA1CEUTICALS LTD, BLOCK B4, COUNTESS COURT, MABUSHI, ABUJA, FCT, NIGERIA 92919163 daitechpharma@gmail.com JIANGSU PENGYAO PHARM CO.LTD., NO.10 CHANQUAN ROAD,JIANGSU PROVINCE,CHINA., China	25/05/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01FA10	Azithromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-6519